Health Care/Hospital

Announcing A New Era In Alzheimer's

MONTE CARLO, Oct. 30, 2012 /PRNewswire/ -- TauRx Therapeutics Ltd announced todaythe initiation of two global Phase 3 clinical trials in mild to moderate Alzheimer's disease. These landmark studies could provide the first definitive data on a Tau-based approach to disease-modifying and preventative ...

2012-10-30 23:45 2189

European Commission Approves Cialis for the Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia

Cialis becomes the first and only medication approved in the EU for both the signs and symptoms of benign prostatic hyperplasia and erectile dysfunction INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has approved Cialis(R) ...

2012-10-30 21:39 1169

ALIMTA(R) Label Update Approved by European Commission to Reflect Significant Overall Survival Benefits for Specific Lung Cancer Patients

INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has approved an update to the label for ALIMTA(R) (pemetrexed for injection), adding final overall survival data to the continuation maintenance indication for patients with adv...

2012-10-30 21:22 1144

Fortis to Elevate Healthcare Delivery with Next Generation Quaternary Care Hospital, A First for India and Asia

GURGAON, India, Oct. 30, 2012 /PRNewswire/ -- Fortis Memorial Research Institute to offer advanced multi-clinical, holistic treatments for complex Medical problems Fortis Healthcare Limited (Fortis), India's largest healthcare provider with an expanding global footprint, today articulated its ...

2012-10-30 09:30 1538

Shanghai Pharmaceuticals Announces 2012 Third Quarterly Report

Operating Revenue & Net Profit Attributable to Shareholders of the Parent Company Surges 27.01% & 12.15% respectively HONG KONG, Oct. 29, 2012 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; ...

2012-10-29 23:39 1477

Frost & Sullivan Recognizes Vidyo for Outstanding Customer Value in Traditional and New Applications for Videoconferencing in Healthcare

Vidyo sets itself apart by keeping ahead of the curve and implementing its products and services in novel ways MOUNTAIN VIEW, Calif., Oct. 29, 2012 /PRNewswire/ -- Based on its recent analysis of the video telemedicine market, Frost & Sullivan recognizes Vidyo with the 2012 North American Frost ...

2012-10-29 22:19 771

AstraZeneca Begins a New Global Study of FASLODEX(R) (Fulvestrant) 500 mg Injection in Patients With Hormone Receptor-Positive Advanced Breast Cancer

LONDON, Oct. 29, 2012/PRNewswire/ -- FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naive advanced breast cancer) trial to compare fulvestrant to anastrozole (ARIMIDEX(R)) tablets in hormonal therapy-naive, postmenopausal patients with hormone receptor-positive locally advanced ...

2012-10-29 20:00 1092

Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results

BEIJING, Oct. 29, 2012 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of vaccines in China, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2012, before market on Thursday, November 15, 2012. The Company will host...

2012-10-29 20:00 807

Serials Solutions Summon Service Expands Japanese-language Content with Japan Medical Abstracts Society

Mutual customers will have access to article abstracts from 5,800 journals SEATTLE, Oct. 29, 2012 /PRNewswire/ -- Serials Solutions(R)( http://www.serialssolutions.com ), a ProQuest(R) business and the Japan Medical Abstracts Society (JAMAS) have dramatically improved access to Japanese-language ...

2012-10-29 09:00 1205

Grand opening of Heraeus Medical Components facility in Singapore

- Heraeus Singapore to include Medical Components Division - Growing Medical Device cluster in Southeast Asia SINGAPORE, Oct. 29, 2012 /PRNewswire/ -- Heraeus announces the opening of a new Singapore facility to support expansion of their Medical Components Division. This Singapore expansion ...

2012-10-29 07:32 1624

Sigma-Aldrich Enhances Customer Focus in China - Unveils Dynamic New Website and Expands Product Offering Through Vetec Brand

ST. LOUIS, Oct. 29, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced the launch of a redesigned website for China, www.sigmaaldrich.com/china, which offers more relevant content, improved search results, enhanced product detail pages and a completely translated homepage...

2012-10-29 07:00 1889

Substantial Clinical Evidence and Adoption Presented at Accuray's TomoTherapy(R) Asia Pacific Users' Meeting 2012

Fifth Users' Meeting Highlights Efficacy of TomoTherapy(R) Treatment System and Widespread Acceptance Across the Region SUNNYVALE, Calif., Oct. 26, 2012 /PRNewswire/ -- Accuray Incorporated( http://www.accuray.com ) (Nasdaq: ARAY), the premier radiation oncology company, showcased new clinical re...

2012-10-26 20:30 1588

"Touch Your Heart, Donate for Love" Blood Drive Enrolls Corporates

Daphne Joins Hands With Touchmedia To Help Shanghai Blood Bank SHANGHAI, Oct.26, 2012 /PRNewswire/ -- Jointly launched by Touchmedia and the Shanghai Blood Center, the "Touch Your Heart, Donate for Love" Blood Drive campaign has expanded from warm-hearted individuals to warm-hearted corporations....

2012-10-26 18:52 1220

Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan

Limited spending places responsibility on manufacturers to develop innovative and cost-effective offerings LONDON, Oct. 26, 2012 /PRNewswire/ -- Limited hospital spending and lengthy equipment replacement spans are slowing down growth rates in the European anesthesia equipment and associated peri...

2012-10-26 02:56 875

Cross Match Technologies Undoubtedly Offers the Highest Value to Customers in the North American Biometrics Market, Says Frost & Sullivan

The company has edged out competition by its steadfast focus on providing products with unparalleled quality for specific end-user applications MOUNTAIN VIEW, Calif., Oct. 25, 2012 /PRNewswire/ -- Based on its recent analysis of the biometrics market, Frost & Sullivan recognizes Cross Match Techn...

2012-10-25 20:15 649

Absence of Alternative Therapies for Psoriatic Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan

Pharmaceutical companies need to introduce safe and effective therapies for patients that do not respond to TNF inhibitors MOUNTAIN VIEW, Calif., Oct. 25, 2012 /PRNewswire/ -- Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic class available to psoriatic arthritis (PsA) pa...

2012-10-25 19:50 541

ABRAXANE(R) Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients

MELBOURNE, Australia, Oct. 25, 2012 /PRNewswire/ -- Specialised Therapeutics Australia Pty Ltd today announced that abstracts for the upcoming Society for Melanoma Research meeting have been published online in the organization's official journal at http://onlinelibrary.wiley.com/doi/10.1111/pcmr.12...

2012-10-25 19:30 809

Policy Makers Join the Call for the Prevention of Atrial Fibrillation-Related Strokes to be Made a National Healthcare Priority

Urgent Need to Reduce the Devastating Personal and Economic Impact of these Severe Strokes BRUSSELS, Oct. 25, 2012 /PRNewswire/ --Ahead of World Stroke Day 2012 (October 29), European Policy Makers have joined over 90 Medical and Patient Organisations, and more than 100,000 people, in supporting ...

2012-10-25 09:45 1203

Policy Makers Join the Call for the Prevention of Atrial Fibrillation-Related Strokes to be Made a National Healthcare Priority

Urgent Need to Reduce the Devastating Personal and Economic Impact of these Severe Strokes BRUSSELS, Oct. 25, 2012 /PRNewswire/ -- Ahead of World Stroke Day 2012 (October 29), European and Malaysian Policy Makers have joined over 90 Medical and Patient Organisations, and more than 100,000 people,...

2012-10-25 09:45 975

DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone

OSAKA, Japan, Oct. 25, 2012 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd. ("DSP") (Headquarters: Osaka, Japan) and Takeda Pharmaceutical Company Limited ("Takeda") (Headquarters: Osaka, Japan) today announced that the European Medicines Agency (EMA) has confirmed the acceptance for review o...

2012-10-25 08:00 982